Osmotica Pharmaceuticals Plc

NASDAQ:OSMT   3:59:54 PM EDT
3.39
+0.06 (+1.80%)
Debt Financing / Related, Products, Divestitures / Spin-offs

Osmotica Pharmaceuticals PLC Announces Conclusion Of Strategic Process With Agreement For The Sale Of Legacy Business To Alora Pharmaceuticals, Llc

Published: 06/25/2021 11:00 GMT
Osmotica Pharmaceuticals Plc (OSMT) - Osmotica Pharmaceuticals Plc Announces Conclusion of Strategic Process With Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, Llc.
Osmotica Pharmaceuticals - Alora Will Acquire Co's Portfolio of Legacy Products and Its Marietta, Georgia Manufacturing Facility, for Up to $170 Million.
Osmotica Pharmaceuticals - Will Receive $110 Million Upfront Cash Payment, With Potential to Receive Up to $60 Million in Additional Milestone Payments.
Osmotica Pharmaceuticals - Will Retain Rvl Pharmaceuticals Business Focused on Ophthalmology and Aesthetics, Led by Its Flagship Product, Upneeq.
Osmotica Pharmaceuticals - Will Also Retain Arbaclofen Extended-release Tablets in Development to Treat Multiple Sclerosis Spasticity.